{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:27:58Z","timestamp":1789943278623,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jaci.2014.12.1911","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T09:20:50Z","timestamp":1422350450000},"page":"1494-1501.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber"],"prefix":"10.1016","volume":"135","author":[{"given":"Hendrik","family":"Nolte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Zieglmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Zieglmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lemell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5914-7830","authenticated-orcid":false,"given":"Friedrich","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2014.12.1911_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1398-9995.1997.tb00991.x","article-title":"Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity","volume":"52","author":"Pichler","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib2","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2500\/ajra.2010.24.3508","article-title":"Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis","volume":"24","author":"Riechelmann","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.12932\/AP0276.31.3.2013","article-title":"Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy","volume":"31","author":"Yukselen","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/alr.21037","article-title":"A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy","volume":"2","author":"Hsu","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2014.12.1911_bib6","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2013.09.004","article-title":"An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies","volume":"132","author":"Calderon","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1398-9995.2011.02669.x","article-title":"European Academy of Allergy and Clinical Immunology task force report on \u201cdose-response relationship in allergen-specific immunotherapy\u201d","volume":"66","author":"Calderon","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/all.12373","article-title":"Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure","volume":"69","author":"Durham","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1398-9995.2010.02473.x","article-title":"The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy","volume":"66","author":"Devillier","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.anai.2013.07.019","article-title":"Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge","volume":"111","author":"Ellis","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaci.2012.03.031","article-title":"Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes","volume":"130","author":"Jacobs","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib12","first-page":"154","article-title":"Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children","volume":"24","author":"Corzo","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0091-6749(05)80006-5","article-title":"Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States","volume":"90","author":"Arlian","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/289592a0","article-title":"Mite faeces are a major source of house dust allergens","volume":"289","author":"Tovey","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2014.12.1911_bib15","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1185\/03007990802155792","article-title":"Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber","volume":"24","author":"Zieglmayer","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2014.12.1911_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1185\/030079904125003700","article-title":"A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit\u2014the Vienna Challenge Chamber (VCC)","volume":"20","author":"Stubner","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2014.12.1911_bib17","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib18","doi-asserted-by":"crossref","first-page":"AB37","DOI":"10.1016\/j.jaci.2012.12.816","article-title":"Efficacy of house dust mite sublingual immunotherapy in adults with allergic rhinitis: results of an environmental exposure chamber study","volume":"131","author":"Roux","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib19","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/lary.23935","article-title":"Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"123","author":"Wang","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2014.12.1911_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cea.12039","article-title":"House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis","volume":"43","author":"Bozek","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2014.12.1911_bib21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(96)70135-5","article-title":"Interpretation of rhinoconjunctivitis quality of life questionnaire data","volume":"98","author":"Juniper","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2014.12.1911_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A\u00a0statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914037117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674914037117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:52:11Z","timestamp":1758790331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674914037117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0091674914037117"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1911","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}